Sentences with phrase «ii study»

Associations between social position, retrospectively recalled parental style and childhood emotional and physical deprivation and attachment were examined in 7,276 civil servants from the Whitehall II Study.

The relationship between parenting dimensions and adult achievement: evidence from the whitehall ii study.

The LYFE - II study is designed to deliver and test with Latino families a culturally adapted version of OSLC's Parent Management Training.

Relative contribution of early life and adult socioeconomic factors to adult morbidity in the Whitehall II study.

This project provides for a facility planning Phase II study to develop preliminary design (35 % level of completion) of bike and pedestrian facilities for a one - mile section of Goldsboro Road between MacArthur Boulevard and River Road.

Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study

Key Insight: In particular, during the Whitehall II study, the salivary cortisol slope was a strong predictor in terms of death than anything else (even smoking status).

One of the most fascinating studies that I have read about, with regards to cortisol slope, is known as the Whitehall II study (5).

Akbaraly, T. N., Sabia, S., Shipley, M. J., Batty, G. D. & Kivimaki, M. Adherence to healthy dietary guidelines and future depressive symptoms: evidence for sex differentials in the Whitehall II study.

Kumari, M., Head, J. & Marmot, M. Prospective Study of Social and Other Risk Factors for Incidence of Type 2 Diabetes in the Whitehall II Study.

We thank all participating women and men in the Whitehall II Study, as well as all Whitehall II research scientists, study and data managers and clinical and administrative staff who make the study possible.

The UK Medical Research Council, British Heart Foundation, and the US National Institutes of Health (R01HL36310, R01AG013196) have supported collection of data in the Whitehall II Study.

We analysed repeated measures (23,245 person - observations) from the Whitehall II study using random effects regression.

Reduced intake of saturated fat and meat: The high intake of saturated fat and meat may be a part of the reason that breast cancer is much more common in areas where Western diets prevail.In the Nurses» Health II Study, premenopausal women who ate the most fat had a slightly increased risk for breast cancer.

By contrast, in the NHS II study there was a much smaller difference in red meat consumption between the white and brown rice eaters — and the white rice eaters actually had a slightly lower incidence of diabetes.

Co-authors on this paper included W. Jack Rejeski and Anthony Marsh, co-principal investigators of the CLIP - II study, and Jessica Sheedy, Beverly Nesbit and Jill Gaukstern, all of the Wake Forest University Department of Health and Exercise Science; and Walter Ambrosius, Michael Walkup, Jonathan Burdette and Barbara Nicklas of the Wake Forest School of Medicine.

Kumari et al. «Maternal separation in childhood and diurnal cortisol patterns in mid-life: findings from the Whitehall II study.»

Evidence from the Whitehall II Study.

A Phase II Study on Safety and Efficacy of High - dose N - acetylcysteine in Patients with Cystic Fibrosis.

The Adventist II study, which may be most informative for those following plant based diets because it includes sizeable populations of vegans / vegetarians, found that meat, legumes (but not soy) and meat analogues were all associated with reduced fracture risk (independently of each other).

Using data from the NHANES II Study, researchers investigated the link between protein intake and mortality in men and women age 50 and over.

Wikipedia: John Harvey Kellogg Kumari M, Shipley M, Stafford M, Kivimaki M. Association of diurnal patterns in salivary cortisol with all - cause and cardiovascular mortality: findings from the Whitehall II study.

CALM study: secondary endpoints of a phase II study of a novel oncolytic immunotherapeutic agent, coxsackievirus A21, delivered intratumorally in patients with advanced malignant melanoma.

Early data from a small phase Ib / II study [23] of ipilimumab combined with T - VEC, which demonstrated that the combination offers much higher complete and overall response rates than have been seen with either agent alone, appear to confirm that there are beneficial synergies between these two therapeutic modalities.

Establishment of a collaboration with the European Lung Cancer Working Party which led to a phase II study on patients with refractory or relapsing small cell lung cancer (clinical trial # 1081 - http://www.elcwp.org/).

Our 80 - subject, multicenter, international phase II study [16] enrolled patients with measurable stage III / IV melanoma.

The phase II part of a phase Ib / II study (ClinicalTrials.gov identifier: NCT02263508; MASTERKEY - 265)[24] assessing the safety and efficacy of T - VEC in combination with the PD - 1 — blocking antibody pembrolizumab in previously untreated, unresected stage IIIB / IV melanoma is evaluating confirmed ORR by irRECIST at week 24.

A phase II study (ACE - LY - 004) reported in The Lancet by Michael Wang, MD, of The University of Texas MD Anderson Cancer Center, and colleagues showed durable responses...

The Shuttle II study began as an Agency activity in January 1985.

A004 is a phase II study of an HIV candidate vaccine Ad26 prime with MVA and protein boost funded and sponsored by Janssen, a division of J&J.

Methods: In a multicenter, randomized, patient - and rater - blind, controlled, parallel - group, phase II study, 42 AD patients were assigned (1: 1) to PE treatment or control (sham) groups.

This approval was granted based on the results of a phase II study of 63 qualifying patients receiving 560 - mg ibrutinib once daily.

In a phase II study, voxtalisib, which targets all four class I PI3Ks, had efficacy in FL but limited clinical effect in MCL, DLBCL, and CLL / SLL.

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.

In this double - blind, placebo - controlled phase II study (NCT00848692), 30 CFS patients were randomised to either Rituximab 500 mg / m2 or saline, given twice two weeks apart, with follow - up for 12 months.

«Promising clinical activity and tolerability of the combination of encorafenib and binimetinib has been seen in patients with BRAF V600 — mutated melanoma in a phase Ib / II and a phase II study,» wrote study authors led by Reinhard Dummer, MD, of the University Hospital Zurich in Switzerland.

Based on those previous signals, Somaiah and colleagues conducted a phase II study testing the anti — PDL - 1 agent durvalumab in combination with the anti — CTLA - 4 agent tremelimumab in multiple sarcoma subtypes.

The combination of pomalidomide plus low - dose dexamethasone showed efficacy with high rates of disease control in relapsed or refractory multiple myeloma patients with severe renal impairment, according to the results of a phase II study.

Work stress, obesity and the risk of type 2 diabetes: gender - specific bidirectional effect in the Whitehall II study

Data from a phase II study of cabozantinib (XL184) in patients with advanced solid tumors show that the drug has activity in both bone and soft tissue.

Phase II study of nilotinib in melanoma harboring KIT alterations following progression to prior KIT inhibition.

Phase II study of cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second - line therapy of small cell lung cancer (NCI # 7097).

Phase I / II study of inhaled doxorubicin combined with platinum - based therapy for advanced non-small cell lung cancer.

Phase I / II Study of Cisplatin plus Romidepsin and Nivolumab in Metastatic Triple Negative Breast Cancer or BRCA Mutation - Associated Locally Recurrent or Metastatic Breast Cancer

A Phase I / II Study of Pembrolizumab (MK - 3475) in Children with Advanced Melanoma or a PD - L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma

Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis after Radiosurgery for Brain Metastases

Phase I / II Study to Evaluate the Safety, Efficacy, and Novel PET / CT Imaging Biomarkers of CB - 839 in Combination with Panitumumab and Irinotecan in Patients with Metastatic and Refractory RAS Wildtype Colorectal Cancer

PELOPS: Palbociclib and Endocrine Therapy for Lobular Breast Cancer Preoperative Study: A Randomized Phase II Study of Palbociclib with Endocrine Therapy versus Endocrine Therapy Alone for Invasive Lobular Carcinoma and Invasive Ductal Carcinoma

A Randomized, Double - Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First - line Chemotherapy in Patients with Metastatic Urothelial Cancer

An Open Label, Phase II Study of Neratinib in Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification